je.st
news
Tag: diabetes
J&J says its diabetes drug should have same survival edge as Lilly's
2015-10-13 19:12:33| Biotech - Topix.net
REUTERS: Johnson & Johnson said the proven ability of Eli Lilly and Co's rival Jardiance diabetes drug to save lives in a large clinical trial is a benefit that will likely be seen in the entire class of drugs, including J&J's own approved Invokana treatment. Dominic Caruso, J&J's chief financial officer, on Tuesday gave his optimistic view of the new drug class, called SGLT2 inhibitors, during a conference call with industry analysts to discuss the company's third-quarter earnings.
Tags: drug
edge
survival
diabetes
International Scientific Forum on Alcohol Research Critique 172: Alcohol and the risk of developing diabetes
2015-10-08 14:48:00| Daily beverage news and comment - from just-drinks.com
Prospective cohort studies for decades have tended to show that the risk of developing Type II diabetes mellitus is reduced among moderate drinkers in comparison with non-drinkers.
Tags: forum
international
research
risk
MARIZEV (Omarigliptin), Mercks Once-Weekly DPP-4 Inhibitor for Type 2 Diabetes, Approved in Japan
2015-09-28 13:30:00| Merck.com - Product News
Dateline City: KENILWORTH, N.J. KENILWORTH, N.J.--(BUSINESS WIRE)--Merck (NYSE:MRK), known as MSD outside the United States and Canada, today announced that the Japanese Pharmaceuticals and Medical Devices Agency (PMDA) has approved MARIZEV (omarigliptin) 25 mg and 12.5 mg tablets, an oral, once-weekly DPP-4 inhibitor indicated for the treatment of adults with type 2 diabetes. Japan is the first country to have approved omarigliptin. Language: English Contact: Media Contacts:Pam Eisele, 267-305-3558orMichael Close, 310-617-1067orKristen Drake, 908-236-4223orInvestor Contacts:Justin Holko, 908-740-1879orTeri Loxam, 908-740-1986 Ticker Slug: Ticker: MRK Exchange: NYSE read more
Novo Nordisk successfully completes diabetes drug phase 3a trial
2015-09-26 03:39:15| Biotech - Topix.net
Danish pharmaceutical company Novo Nordisk has successfully completed the second phase 3a trial with its diabetes drug semaglutide, it said on Friday.
Tags: trial
drug
phase
successfully
Study: Type 2 diabetes pill Jardiance cuts risk of death
2015-09-21 17:51:37| Biotech - Topix.net
Jardiance sharply reduced chances of dying in diabetic patients at high risk of heart complications, a study shows, making the Type 2 diabetes medication the first shown to lengthen diabetics' lives. The study found Jardiance reduced deaths from heart complications by 38 percent, deaths from any cause by 32 percent and hospitalizations due to chronic heart failure by 35 percent.
Sites : [1] [2] [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] [14] [15] next »